查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1782020

液体活检市场，按样本类型、按生物标记、按技术、按产品、按临床应用、按应用、按最终用户、按国家/地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额及预测

Liquid Biopsy Market, By Sample Type, By Biomarker, By Technology, By Product, By Clinical Application, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 383 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年液体切片市场规模价值 121.2424 亿美元，2025 年至 2032 年的复合年增长率为 11.6%。

液体切片市场-市场动态

预计癌症盛行率的上升将推动早期筛检和治疗的需求，从而推动市场成长。

随着癌症成为全球发病率和死亡率的主要原因，医疗保健系统越来越重视早期诊断，以便在恶性肿瘤发展之前发现它们。这种转变推动了先进筛检技术的使用，包括液体活检、影像技术和分子诊断评估。美国国家癌症研究所预测，到2025年，美国将新增约2,041,910例癌症病例，其中618,120例死于癌症。因此，涵盖早期诊断到治疗的癌症护理全过程正在快速发展，以满足日益增长的医疗保健需求，从而进一步刺激早期筛检工具和突破性疗法的市场发展。此外，基因组学和分子技术的进步可能为市场带来成长机会。然而，缺乏标准化和监管障碍可能会阻碍市场扩张。

液体活检市场－关键见解

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 11.6%。

根据样本类型细分，预计血液样本将在 2024 年占据最大市场份额

根据生物标记细分，循环肿瘤细胞 (CTC) 是 2024 年的主要应用

根据技术细分，多基因平行分析 (NGS) 是 2024 年的领先技术

根据产品细分，仪器是 2024 年的主导产品

根据临床应用细分，治疗选择是 2024 年领先的最终用户

根据应用程式细分，癌症是 2024 年领先的最终用户

根据最终用户细分，医院和实验室是 2024 年的主要最终用户

从地区来看，北美是 2024 年最大的收入来源

液体活检市场-細項分析：

全球液体活检市场根据样本类型、应用、技术、产品、临床应用、应用、最终用户和地区进行细分。

根据样本类型，市场分为三个部分：血液样本和其他样本。血液样本是市场成长的主要驱动力。血液样本在液体活检领域占据主导地位，主要是因为其易于采集、侵入性低且患者依从性高。以血液为基础的液体活检有助于检测和分析循环肿瘤DNA (ctDNA)、循环肿瘤细胞 (CTC) 和其他各种生物标记物，从而即时全面地概述肿瘤的基因图谱。与组织切片相比，血液样本为癌症诊断、预后、治疗监测和早期检测提供了更快速、更安全、更经济的选择。医院、诊断中心和研究机构广泛采用以血液为基础的检测，进一步巩固了其在市场上的领先地位。

根据生物标记，市场可分为三个细分领域：循环肿瘤细胞 (CTC)、循环肿瘤DNA (ctDNA) 和细胞外载体 (EV) 等。循环肿瘤细胞 (CTC) 引领着市场的成长。 CTC 是液体活检市场成长的主要驱动力，因为它们在癌症诊断、预后和治疗监测中发挥重要作用。 CTC 是从原发性或转移性肿瘤中分离出来并在血液中传播的癌细胞，为了解肿瘤异质性和转移潜能提供了重要资讯。 CTC 无需侵入性操作即可提供疾病进展和治疗反应的即时资料，使其成为肿瘤学中首选的生物标记。

根据技术，市场可分为两大细分领域：多基因平行分析 (NGS) 和单基因分析（PCR 微阵列）。多基因平行分析 (NGS) 是市场成长的主要驱动力。利用新一代定序 (NGS) 进行的多基因平行分析，能够同时评估多种基因变异，并具有卓越的灵敏度和特异性，从而推动了液体活检市场的成长。 NGS 能够从小样本量中进行广泛的基因组分析，使临床医生能够深入了解肿瘤生物学、突变负荷和可能的治疗标靶。该方法尤其有利于个人化医疗，因为它能够即时识别罕见突变和抗药性机制。基于 NGS 的液体活检组合在肿瘤学中的应用日益广泛，用于早期癌症检测、治疗选择和微小残留疾病的监测，这极大地促进了市场的成长。

市场依产品细分为三类：仪器、耗材、试剂盒及试剂，以及软体及服务。仪器引领着市场的成长。仪器处于液体活检市场扩张的前沿，这得益于对能够准确识别和分析循环生物标记（例如循环肿瘤细胞 (CTC)、循环肿瘤 DNA (ctDNA) 和外泌体）的尖端技术日益增长的需求。这些仪器包括 NGS 平台、PCR 系统、微流体设备和自动化液体处理系统，对于实现诊断过程的高通量、灵敏度和精确度至关重要。专为肿瘤学应用而设计的创新、用户友好和整合系统的不断发展，加速了其在医院、诊断实验室和研究机构中的应用。

根据临床应用，市场可分为四个细分领域：疗法选择、治疗监测、早期癌症筛检、復发监测等。疗法选择是市场成长的主要驱动力。透过检测循环肿瘤DNA (ctDNA) 或其他生物标记物，液体活检无需进行侵入性组织取样即可检测特定突变、基因融合和抗药性机制。这种方法使肿瘤学家能够根据患者独特的分子特征量身定制治疗方案，例如标靶治疗或免疫治疗，从而改善临床疗效并减少不必要的毒性。精准医疗日益受到关注，加上液体活检能够追踪治疗过程中肿瘤的动态变化，进一步强化了其在不同癌症类型疗法选择中的重要作用。

根据应用，市场可分为八个部分：癌症、生殖健康、肺癌、摄护腺癌、乳癌、大肠癌、白血病、胃肠道癌症和其他。癌症部分处于市场成长的前沿。在液体活检领域，癌症部分正在推动市场扩张，这得益于全球各种癌症患病率的上升以及对非侵入性诊断方法的需求不断增长。液体活检透过检查来自体液（主要是血液）的生物标记（例如 ctDNA、CTC 和外泌体），为癌症的早期发现、肿瘤分析、治疗监测和预测復发提供了一种革命性的方法。与传统组织活检相比，它具有降低风险、缩短週转时间以及捕捉肿瘤异质性的能力等优势，使其成为肿瘤学的重要工具。随着精准医疗在癌症治疗中变得越来越重要，液体活检在肺癌、乳腺癌、大肠直肠癌和前列腺癌等实体肿瘤管理中的应用不断增长，进一步推动了这一领域的发展。

根据最终用户，市场可分为四个细分市场：医院和实验室、专科诊所、学术和研究中心以及其他。医院和实验室细分市场处于市场成长的前沿。由于先进诊断技术的普及以及在这些环境中进行的癌症筛检和监测程序的增多，该细分市场正在推动液体活检行业的扩张。医院和临床实验室通常是接受诊断评估的患者最初的接触点，因此它们成为部署液体活检测试的重要中心。这些机构的优势在于拥有熟练的专业人员、完善的基础设施以及可使用NGS和PCR平台等高通量仪器。

液体活检市场——地理洞察

北美市场成长领先，这归功于其强大的研发实力和完善的报销框架。该地区完善的医疗保健体系提高了人们对早期癌症筛检的认识，学术机构与行业利益相关者之间强有力的合作进一步巩固了北美在全球液体活检市场的突出地位。根据美国医学会 (American Medical Association) 报道，美国在 2023 年的医疗保健拨款为 4.8665 兆美元。由于癌症认知度的提高、医疗保健可近性的提升以及政府对早期检测计划的资助，欧洲也占据了相当大的市场份额。

液体切片市场-竞争格局：

液体切片市场竞争激烈，不断发展变化，许多老牌企业和新进者都力求透过创新、合作和成长策略来巩固竞争优势。各家公司正利用诸如新一代定序 (NGS)、液滴式数位 PCR 和多基因面板检测等尖端技术展开竞争，以提高液体活检检测的灵敏度、特异性和速度。领先的公司正更加重视亚太和拉丁美洲的新兴市场，透过设立区域子公司和分销网络来抓住尚未开发的机会。

最新动态：

2023年11月1日，全球DNA定序与晶片技术领导企业Illumina公司宣布推出新一代分散式液体切片检测系统，用于基因组分析。最新的TruSight Oncology 500 ctDNA v2（TSO 500 ctDNA v2）是一款研究型检测系统，可在无法进行组织检测的情况下，对从血液样本中提取的循环肿瘤DNA (ctDNA) 进行非侵入性全面基因组分析 (CGP)，或增强基于组织的检测。

目录

第一章：液体活检市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 液体活检市场按样本类型划分
    • 液体活检市场片段（按生物标记）
    • 液体切片市场技术片段
    • 液体切片市场产品片段
    • 液体活检市场片段（按临床应用）
    • 液体活检市场片段（按应用）
    • 液体活检市场片段（按最终用户）
    • 液体活检市场（按国家/地区）
    • 液体活检市场（按地区）
  • 竞争洞察

第三章：液体切片检查主要市场趋势

  • 液体活检市场驱动因素
    • 市场驱动因素的影响分析
  • 液体切片市场限制
    • 市场限制的影响分析
  • 液体切片市场机会
  • 液体切片市场未来趋势

第四章：液体活检产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：液体切片市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：液体切片市场格局

  • 2024年液体切片市场份额分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：液体切片市场－依样本类型

  • 概述
    • 依样本类型进行细分份额分析
    • 血液样本
    • 其他的

第 8 章：液体活检市场 - 按生物标记

  • 概述
    • 按生物标誌物细分的市占率分析
    • 循环肿瘤细胞（CTC）
    • 循环肿瘤DNA（ctDNA）
    • 细胞外载体（EV）
    • 其他的

第九章：液体切片市场－依技术

  • 概述
    • 按技术细分的市场份额分析
    • 多基因平行分析（NGS）
    • 单基因分析（PCR微阵列）

第 10 章：液体活检市场 - 按产品

  • 概述
    • 按产品细分的市占率分析
    • 仪器
    • 耗材套件和试剂
    • 软体和服务

第 11 章：液体活检市场 - 按临床应用

  • 概述
    • 按临床应用分類的细分市场份额分析
    • 治疗选择
    • 治疗监测
    • 早期癌症筛检
    • 復发监测
    • 其他的

第 12 章：液体活检市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 癌症
    • 生殖健康
    • 肺癌
    • 摄护腺癌
    • 乳癌
    • 大肠直肠癌
    • 白血病
    • 胃肠道癌症
    • 其他的

第 13 章：液体活检市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院和实验室
    • 专科诊所
    • 学术和研究中心
    • 其他的

第 14 章：液体活检市场-按地域划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美液体活检主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按样本类型）
    • 北美市场规模及预测（依生物标记）
    • 北美市场规模和预测（按技术）
    • 北美市场规模及预测（按产品）
    • 北美市场规模与预测，按临床应用
    • 北美市场规模和预测（按应用）
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲液体切片检查主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（依样本类型）
    • 欧洲市场规模及预测（依生物标记）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模及预测（按产品）
    • 欧洲市场规模与预测，按临床应用
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区液体活检主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依样本类型）
    • 亚太地区生物标记市场规模及预测
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区市场规模及预测（依产品）
    • 亚太地区市场规模及预测（依临床应用）
    • 亚太地区市场规模及预测（按应用）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲液体活检主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依样本类型）
    • 拉丁美洲市场规模及预测（按生物标记）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模及预测（按产品）
    • LATAM 规模及预测（依临床应用）
    • LATAM 规模和预测（按应用）
    • 拉丁美洲地区规模及预测（依最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲液体活检主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按样本类型）
    • 中东和非洲市场规模及预测（按生物标记）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按产品）
    • 中东及非洲市场规模及预测（依临床应用）
    • 中东和非洲市场规模和预测（按应用）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 15 章：液体活检产业主要供应商分析

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Guardant Health, Inc.
    • Foundation Medicine, Inc. (Roche subsidiary)
    • Illumina, Inc.
    • GRAIL, Inc. (subsidiary of Illumina)
    • Bio-Rad Laboratories, Inc.
    • Exact Sciences Corporation
    • Thermo Fisher Scientific Inc.
    • Natera, Inc.
    • Freenome Holdings, Inc.
    • QIAGEN NV
    • Lucence Diagnostics
    • Inivata Ltd. (NeoGenomics subsidiary)
    • Angle plc
    • Sysmex Corporation
    • Biocept, Inc.
    • Oncocyte Corporation
    • Personal Genome Diagnostics (PGDx)
    • Chronix Biomedical
    • Epic Sciences, Inc.
    • Cynvenio Biosystems, Inc.
    • Others

第 16 章：360 度分析师视角

第 17 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5421

REPORT HIGHLIGHT

Liquid Biopsy Market size was valued at US$ 12,124.24 Million in 2024, expanding at a CAGR of 11.6% from 2025 to 2032.

A liquid biopsy is a non-invasive diagnostic procedure that evaluates bodily fluids, mainly blood, to identify cancer or other illnesses. It analyzes biomarkers such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) to detect genetic or molecular alterations linked to a tumor. Liquid biopsies can facilitate early cancer detection, monitor the effectiveness of treatments, and evaluate tumor progression. Much of the initial research on liquid biopsies has focused on lung, breast, and prostate cancers; however, this technology is anticipated to influence all cancer types. Liquid biopsy represents a relatively recent testing method with numerous potential revolutionary applications in cancer therapy, including several uses that have received approval from the U.S. Food and Drug Administration (FDA). Ongoing research continues to explore its advantages.

Liquid Biopsy Market- Market Dynamics

The increasing prevalence of cancer is anticipated to boost the demand for early screening and therapeutics, thereby driving market growth.

As cancer emerges as a primary contributor to morbidity and mortality globally, healthcare systems are increasingly prioritizing early-stage diagnostics to detect malignancies before their advancement. This shift is propelling the utilization of sophisticated screening technologies, including liquid biopsies, imaging techniques, and molecular diagnostic assessments. The National Cancer Institute projects that by 2025, approximately 2,041,910 new cancer cases will be identified in the United States, with 618,120 fatalities attributed to the disease. Consequently, the cancer care continuum, encompassing early diagnosis through to treatment, is rapidly evolving to address the escalating healthcare demands, thereby further stimulating the market for both early screening instruments and groundbreaking therapeutics. Additionally, advancements in genomic and molecular technologies may present growth opportunities for the market. Nevertheless, the lack of standardization and regulatory hurdles could impede market expansion.

Liquid Biopsy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.6% over the forecast period (2025-2032)

Based on the Sample Type segmentation, the Blood Sample was predicted to show maximum market share in the year 2024

Based on Biomarker segmentation, Circulating Tumor Cells (CTCs) were the leading application in 2024

Based on Technology segmentation, Multi-gene-parallel Analysis (NGS) was the leading Technology in 2024

Based on Product segmentation, Instruments were the leading Product in 2024

Based on Clinical application segmentation, Therapy Selection was the leading End-User in 2024

Based on Application segmentation, Cancer was the leading End-User in 2024

Based on End-User segmentation, Hospitals and Laboratories were the leading End-User in 2024

Based on region, North America was the leading revenue generator in 2024

Liquid Biopsy Market- Segmentation Analysis:

The Global Liquid Biopsy Market is segmented based on Sample Type, Application, Technology, Product, Clinical Application, Application, End-User, and Region.

The market is categorized into three segments according to Sample Type: Blood Sample and Others. Blood Sample is the primary driver of market growth. Blood samples dominate the Liquid Biopsy sector, mainly due to their ease of collection, low invasiveness, and high levels of patient compliance. Blood-based liquid biopsies facilitate the detection and analysis of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and various other biomarkers, providing a thorough overview of the tumor's genetic profile in real-time. In comparison to tissue biopsies, blood samples offer a quicker, safer, and more economical option for cancer diagnosis, prognosis, treatment monitoring, and early detection. The extensive adoption of blood-based tests by hospitals, diagnostic centers, and research institutions further reinforces their leading position in the market.

The market is categorized into three segments based on biomarkers: Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), and Extracellular Vehicles (EVs), among others. Circulating Tumor Cells (CTCs) lead the growth of the market. CTCs are the primary drivers of growth in the Liquid Biopsy market, due to their significant role in cancer diagnosis, prognosis, and treatment monitoring. CTCs are cancer cells that separate from primary or metastatic tumors and travel through the bloodstream, providing essential insights into tumor heterogeneity and metastatic potential. Their capacity to deliver real-time data on disease progression and treatment response without requiring invasive procedures renders them a preferred biomarker in oncology.

The market is categorized into two segments based on technology: Multi-gene-parallel Analysis (NGS) and Single Gene Analysis (PCR Microarrays). Multi-gene-parallel Analysis (NGS) is the primary driver of market growth. The multi-gene parallel analysis utilising Next-Generation Sequencing (NGS) leads to the growth of the Liquid Biopsy market, owing to its capability to concurrently assess multiple genetic alterations with exceptional sensitivity and specificity. NGS facilitates extensive genomic profiling from small sample volumes, equipping clinicians with in-depth insights into tumor biology, mutation load, and possible therapeutic targets. This methodology is particularly beneficial for personalized medicine, as it enables the identification of rare mutations and resistance mechanisms in real time. The rising implementation of NGS-based liquid biopsy panels in oncology for early cancer detection, treatment selection, and monitoring of minimal residual disease is greatly enhancing the market's growth.

The market is segmented into three categories based on Product: Instruments, Consumables Kits and Reagents, and Software and Services. Instruments lead the growth of the market. Instruments are at the forefront of the Liquid Biopsy market expansion, propelled by the rising demand for sophisticated technologies that can accurately identify and analyze circulating biomarkers such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and exosomes. These instruments, which include NGS platforms, PCR systems, microfluidic devices, and automated liquid handling systems, are crucial for achieving high throughput, sensitivity, and precision in diagnostic processes. The ongoing advancement of innovative, user-friendly, and integrated systems designed for oncology applications has accelerated their adoption in hospitals, diagnostic laboratories, and research institutions.

The market is categorized into four segments based on Clinical Application: Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring, and Others. Therapy Selection is the primary driver of market growth. By examining circulating tumor DNA (ctDNA) or other biomarkers, liquid biopsy facilitates the detection of specific mutations, gene fusions, and resistance mechanisms without requiring invasive tissue sampling. This method enables oncologists to customize therapies such as targeted treatments or immunotherapies according to a patient's distinct molecular profile, thereby enhancing clinical outcomes and reducing unnecessary toxicity. The increasing focus on precision medicine, coupled with the capability of liquid biopsy to track dynamic tumor alterations during treatment, further reinforces its essential role in therapy selection across different cancer types.

The market is categorized into eight segments based on application: Cancer, Reproductive Health, Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Gastrointestinal Cancer, and Others. The cancer segment is at the forefront of market growth. In the Liquid Biopsy sector, the cancer segment is driving market expansion, propelled by the increasing global prevalence of various cancers and the rising demand for non-invasive diagnostic methods. Liquid biopsy provides a revolutionary method for the early detection of cancer, tumor profiling, treatment monitoring, and predicting relapses by examining biomarkers such as ctDNA, CTCs, and exosomes derived from body fluids-mainly blood. Its benefits over conventional tissue biopsies, which include reduced risk, faster turnaround times, and the capacity to capture tumor heterogeneity, have established it as an essential instrument in oncology. As precision medicine becomes more integral to cancer treatment, the application of liquid biopsy in the management of solid tumors like lung, breast, colorectal, and prostate cancer is continually growing, further propelling the advancement of this segment.

The market is categorized into four segments based on End-User: Hospitals and Laboratories, Specialty Clinics, Academic and Research Centers, and Others. The Hospitals and Laboratories segment is at the forefront of market growth. This segment is driving the expansion of the Liquid Biopsy industry due to the increasing adoption of advanced diagnostic technologies and the growing number of cancer screening and monitoring procedures conducted in these environments. Hospitals and clinical laboratories frequently serve as the initial point of contact for patients undergoing diagnostic assessments, rendering them essential centers for the deployment of liquid biopsy tests. These institutions gain advantages from the presence of skilled professionals, established infrastructure, and access to high-throughput instruments such as NGS and PCR platforms.

Liquid Biopsy Market- Geographical Insights

North America leads in market growth, attributed to robust research and development as well as a solid reimbursement framework. The region's sophisticated healthcare system heightened awareness regarding early cancer screening, and strong partnerships between academic institutions and industry stakeholders further solidify North America's prominent role in the global liquid biopsy market. As reported by the American Medical Association, the United States allocated USD 4,866.5 billion for healthcare in 2023. Europe also orders a substantial portion of the market, bolstered by increasing cancer awareness, enhanced access to healthcare, and government funding for early detection initiatives.

Liquid Biopsy Market- Competitive Landscape:

The liquid biopsy market is characterized by intense competition and constant evolution, with numerous established and new entrants seeking to secure a competitive advantage through innovation, collaborations, and growth strategies. Firms are competing based on cutting-edge technologies such as next-generation sequencing (NGS), droplet digital PCR, and multi-gene panel testing to enhance the sensitivity, specificity, and speed of liquid biopsy assays. Leading companies are placing greater emphasis on emerging markets in the Asia Pacific and Latin America by setting up regional subsidiaries and distribution networks to seize untapped opportunities.

Recent Developments:

On November 1, 2023, Illumina Inc., a worldwide frontrunner in DNA sequencing and array-based technologies, announced the launch of a new generation of its distributed liquid biopsy assay designed for genomic profiling. The latest TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2) is a research assay that facilitates noninvasive comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) extracted from blood samples when tissue testing is not feasible, or enhances tissue-based testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIQUID BIOPSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Guardant Health, Inc.
  • Foundation Medicine, Inc. (Roche subsidiary)
  • Illumina, Inc.
  • GRAIL, Inc. (a subsidiary of Illumina)
  • Bio-Rad Laboratories, Inc.
  • Exact Sciences Corporation
  • Thermo Fisher Scientific Inc.
  • Natera, Inc.
  • Freenome Holdings, Inc.
  • QIAGEN N.V.
  • Lucence Diagnostics
  • Inivata Ltd. (NeoGenomics subsidiary)
  • Angle plc
  • Sysmex Corporation
  • Biocept, Inc.
  • Oncocyte Corporation
  • Personal Genome Diagnostics (PGDx)
  • Chronix Biomedical
  • Epic Sciences, Inc.
  • Cynvenio Biosystems, Inc.
  • Others

GLOBAL LIQUID BIOPSY MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Blood Sample
  • Others

GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER- MARKET ANALYSIS, 2019 - 2032

  • Circulating Tumor Cells (CTCs)
  • Circulating Tumor DNA (ctDNA)
  • Extracellular Vehicles (EVs)
  • Others

GLOBAL LIQUID BIOPSY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Multi-gene-parallel Analysis (NGS)
  • Single Gene Analysis (PCR Microarrays)

GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Consumables Kits and Reagents
  • Software and Services

GLOBAL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Therapy Selection
  • Treatment Monitoring
  • Early Cancer Screening
  • Recurrence Monitoring
  • Others

GLOBAL LIQUID BIOPSY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Reproductive Health
  • Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Leukemia
  • Gastrointestinal Cancer
  • Others

GLOBAL LIQUID BIOPSY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Laboratories
  • Specialty Clinics
  • Academic and Research Centers
  • Others

GLOBAL LIQUID BIOPSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Liquid Biopsy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Liquid Biopsy Market Snippet by Sample Type
    • 2.1.2. Liquid Biopsy Market Snippet by Biomarker
    • 2.1.3. Liquid Biopsy Market Snippet by Technology
    • 2.1.4. Liquid Biopsy Market Snippet by Product
    • 2.1.5. Liquid Biopsy Market Snippet by Clinical Application
    • 2.1.6. Liquid Biopsy Market Snippet by Application
    • 2.1.7. Liquid Biopsy Market Snippet by End-User
    • 2.1.8. Liquid Biopsy Market Snippet by Country
    • 2.1.9. Liquid Biopsy Market Snippet by Region
  • 2.2. Competitive Insights

3. Liquid Biopsy Key Market Trends

  • 3.1. Liquid Biopsy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Liquid Biopsy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Liquid Biopsy Market Opportunities
  • 3.4. Liquid Biopsy Market Future Trends

4. Liquid Biopsy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Liquid Biopsy Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Liquid Biopsy Market Landscape

  • 6.1. Liquid Biopsy Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Liquid Biopsy Market - By Sample Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
    • 7.1.2. Blood Sample
    • 7.1.3. Others

8. Liquid Biopsy Market - By Biomarker

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Biomarker, 2024 & 2032 (%)
    • 8.1.2. Circulating Tumor Cells (CTCs)
    • 8.1.3. Circulating Tumor DNA (ctDNA)
    • 8.1.4. Extracellular Vehicles (EVs)
    • 8.1.5. Others

9. Liquid Biopsy Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 9.1.2. Multi-gene-parallel Analysis (NGS)
    • 9.1.3. Single Gene Analysis (PCR Microarrays)

10. Liquid Biopsy Market - By Product

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 10.1.2. Instruments
    • 10.1.3. Consumables Kits and Reagents
    • 10.1.4. Software and Services

11. Liquid Biopsy Market - By Clinical Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Clinical Application, 2024 & 2032 (%)
    • 11.1.2. Therapy Selection
    • 11.1.3. Treatment Monitoring
    • 11.1.4. Early Cancer Screening
    • 11.1.5. Recurrence Monitoring
    • 11.1.6. Others

12. Liquid Biopsy Market - By Application

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 12.1.2. Cancer
    • 12.1.3. Reproductive Health
    • 12.1.4. Lung Cancer
    • 12.1.5. Prostate Cancer
    • 12.1.6. Breast Cancer
    • 12.1.7. Colorectal Cancer
    • 12.1.8. Leukemia
    • 12.1.9. Gastrointestinal Cancer
    • 12.1.10. Others

13. Liquid Biopsy Market - By End-User

  • 13.1. Overview
    • 13.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 13.1.2. Hospitals and Laboratories
    • 13.1.3. Specialty Clinics
    • 13.1.4. Academic and Research Centers
    • 13.1.5. Others

14. Liquid Biopsy Market- By Geography

  • 14.1. Introduction
    • 14.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 14.2. North America
    • 14.2.1. Overview
    • 14.2.2. Liquid Biopsy Key Manufacturers in North America
    • 14.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.2.4. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 14.2.5. North America Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
    • 14.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 14.2.7. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 14.2.8. North America Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
    • 14.2.9. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.2.10. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.2.11. U.S.
      • 14.2.11.1. Overview
      • 14.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.2.11.3. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.2.11.4. U.S. Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.2.11.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.2.11.6. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.2.11.7. U.S. Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.2.11.8. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.2.11.9. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.2.12. Canada
      • 14.2.12.1. Overview
      • 14.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.2.12.3. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.2.12.4. Canada Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.2.12.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.2.12.6. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.2.12.7. Canada Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.2.12.8. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.2.12.9. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 14.3. Europe
    • 14.3.1. Overview
    • 14.3.2. Liquid Biopsy Key Manufacturers in Europe
    • 14.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.3.4. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 14.3.5. Europe Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
    • 14.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 14.3.7. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 14.3.8. Europe Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
    • 14.3.9. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.3.10. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.3.11. Germany
      • 14.3.11.1. Overview
      • 14.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.11.3. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.3.11.4. Germany Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.3.11.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.3.11.6. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.3.11.7. Germany Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.3.11.8. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.11.9. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.3.12. UK
      • 14.3.12.1. Overview
      • 14.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.12.3. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.3.12.4. UK Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.3.12.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.3.12.6. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.3.12.7. UK Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.3.12.8. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.12.9. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.3.13. France
      • 14.3.13.1. Overview
      • 14.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.13.3. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.3.13.4. France Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.3.13.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.3.13.6. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.3.13.7. France Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.3.13.8. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.13.9. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.3.14. Italy
      • 14.3.14.1. Overview
      • 14.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.14.3. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.3.14.4. Italy Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.3.14.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.3.14.6. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.3.14.7. Italy Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.3.14.8. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.14.9. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.3.15. Spain
      • 14.3.15.1. Overview
      • 14.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.15.3. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.3.15.4. Spain Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.3.15.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.3.15.6. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.3.15.7. Spain Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.3.15.8. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.15.9. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.3.16. The Netherlands
      • 14.3.16.1. Overview
      • 14.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.16.3. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.3.16.4. The Netherlands Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.3.16.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.3.16.6. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.3.16.7. The Netherlands Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.3.16.8. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.16.9. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.3.17. Sweden
      • 14.3.17.1. Overview
      • 14.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.17.3. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.3.17.4. Sweden Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.3.17.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.3.17.6. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.3.17.7. Sweden Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.3.17.8. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.17.9. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.3.18. Russia
      • 14.3.18.1. Overview
      • 14.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.18.3. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.3.18.4. Russia Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.3.18.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.3.18.6. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.3.18.7. Russia Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.3.18.8. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.18.9. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.3.19. Poland
      • 14.3.19.1. Overview
      • 14.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.19.3. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.3.19.4. Poland Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.3.19.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.3.19.6. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.3.19.7. Poland Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.3.19.8. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.19.9. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.3.20. Rest of Europe
      • 14.3.20.1. Overview
      • 14.3.20.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.20.3. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.3.20.4. Rest of the Europe Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.3.20.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.3.20.6. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.3.20.7. Rest of the Europe Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.3.20.8. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.20.9. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 14.4. Asia Pacific (APAC)
    • 14.4.1. Overview
    • 14.4.2. Liquid Biopsy Key Manufacturers in Asia Pacific
    • 14.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.4.4. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 14.4.5. APAC Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
    • 14.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 14.4.7. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 14.4.8. APAC Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
    • 14.4.9. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.4.10. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.4.11. China
      • 14.4.11.1. Overview
      • 14.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.11.3. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.4.11.4. China Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.4.11.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.4.11.6. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.4.11.7. China Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.4.11.8. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.11.9. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.4.12. India
      • 14.4.12.1. Overview
      • 14.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.12.3. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.4.12.4. India Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.4.12.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.4.12.6. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.4.12.7. India Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.4.12.8. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.12.9. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.4.13. Japan
      • 14.4.13.1. Overview
      • 14.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.13.3. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.4.13.4. Japan Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.4.13.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.4.13.6. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.4.13.7. Japan Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.4.13.8. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.13.9. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.4.14. South Korea
      • 14.4.14.1. Overview
      • 14.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.14.3. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.4.14.4. South Korea Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.4.14.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.4.14.6. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.4.14.7. South Korea Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.4.14.8. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.14.9. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.4.15. Australia
      • 14.4.15.1. Overview
      • 14.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.15.3. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.4.15.4. Australia Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.4.15.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.4.15.6. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.4.15.7. Australia Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.4.15.8. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.15.9. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.4.16. Indonesia
      • 14.4.16.1. Overview
      • 14.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.16.3. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.4.16.4. Indonesia Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.4.16.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.4.16.6. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.4.16.7. Indonesia Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.4.16.8. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.16.9. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.4.17. Thailand
      • 14.4.17.1. Overview
      • 14.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.17.3. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.4.17.4. Thailand Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.4.17.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.4.17.6. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.4.17.7. Thailand Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.4.17.8. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.17.9. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.4.18. Philippines
      • 14.4.18.1. Overview
      • 14.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.18.3. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.4.18.4. Philippines Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.4.18.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.4.18.6. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.4.18.7. Philippines Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.4.18.8. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.18.9. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.4.19. Rest of APAC
      • 14.4.19.1. Overview
      • 14.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.19.3. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.4.19.4. Rest of APAC Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.4.19.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.4.19.6. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.4.19.7. Rest of APAC Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.4.19.8. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.19.9. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 14.5. Latin America (LATAM)
    • 14.5.1. Overview
    • 14.5.2. Liquid Biopsy Key Manufacturers in Latin America
    • 14.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.5.4. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 14.5.5. LATAM Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
    • 14.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 14.5.7. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 14.5.8. LATAM Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
    • 14.5.9. LATAM Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.5.10. LATAM Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.5.11. Brazil
      • 14.5.11.1. Overview
      • 14.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.11.3. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.5.11.4. Brazil Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.5.11.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.5.11.6. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.5.11.7. Brazil Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.5.11.8. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.11.9. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.5.12. Mexico
      • 14.5.12.1. Overview
      • 14.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.12.3. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.5.12.4. Mexico Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.5.12.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.5.12.6. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.5.12.7. Mexico Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.5.12.8. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.12.9. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.5.13. Argentina
      • 14.5.13.1. Overview
      • 14.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.13.3. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.5.13.4. Argentina Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.5.13.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.5.13.6. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.5.13.7. Argentina Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.5.13.8. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.13.9. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.5.14. Colombia
      • 14.5.14.1. Overview
      • 14.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.14.3. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.5.14.4. Colombia Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.5.14.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.5.14.6. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.5.14.7. Colombia Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.5.14.8. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.14.9. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.5.15. Rest of LATAM
      • 14.5.15.1. Overview
      • 14.5.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.15.3. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.5.15.4. Rest of LATAM Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.5.15.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.5.15.6. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.5.15.7. Rest of LATAM Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.5.15.8. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.15.9. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 14.6. Middle East and Africa
    • 14.6.1. Overview
    • 14.6.2. Liquid Biopsy Key Manufacturers in Middle East and Africa
    • 14.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.6.4. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 14.6.5. Middle East and Africa Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
    • 14.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 14.6.7. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 14.6.8. Middle East and Africa Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
    • 14.6.9. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.6.10. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.6.11. Saudi Arabia
      • 14.6.11.1. Overview
      • 14.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.11.3. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.6.11.4. Saudi Arabia Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.6.11.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.6.11.6. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.6.11.7. Saudi Arabia Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.6.11.8. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.11.9. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.6.12. United Arab Emirates
      • 14.6.12.1. Overview
      • 14.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.12.3. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.6.12.4. United Arab Emirates Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.6.12.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.6.12.6. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.6.12.7. United Arab Emirates Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.6.12.8. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.12.9. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.6.13. Israel
      • 14.6.13.1. Overview
      • 14.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.13.3. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.6.13.4. Israel Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.6.13.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.6.13.6. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.6.13.7. Israel Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.6.13.8. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.13.9. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.6.14. Turkey
      • 14.6.14.1. Overview
      • 14.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.14.3. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.6.14.4. Turkey Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.6.14.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.6.14.6. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.6.14.7. Turkey Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.6.14.8. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.14.9. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.6.15. Algeria
      • 14.6.15.1. Overview
      • 14.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.15.3. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.6.15.4. Algeria Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.6.15.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.6.15.6. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.6.15.7. Algeria Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.6.15.8. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.15.9. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.6.16. Egypt
      • 14.6.16.1. Overview
      • 14.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.16.3. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.6.16.4. Egypt Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.6.16.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.6.16.6. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.6.16.7. Egypt Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.6.16.8. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.16.9. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 14.6.17. Rest of MEA
      • 14.6.17.1. Overview
      • 14.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.17.3. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 14.6.17.4. Rest of MEA Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
      • 14.6.17.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 14.6.17.6. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 14.6.17.7. Rest of MEA Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
      • 14.6.17.8. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.17.9. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

15. Key Vendor Analysis- Liquid Biopsy Industry

  • 15.1. Competitive Dashboard
    • 15.1.1. Competitive Benchmarking
    • 15.1.2. Competitive Positioning
  • 15.2. Company Profiles
    • 15.2.1. Guardant Health, Inc.
    • 15.2.2. Foundation Medicine, Inc. (Roche subsidiary)
    • 15.2.3. Illumina, Inc.
    • 15.2.4. GRAIL, Inc. (subsidiary of Illumina)
    • 15.2.5. Bio-Rad Laboratories, Inc.
    • 15.2.6. Exact Sciences Corporation
    • 15.2.7. Thermo Fisher Scientific Inc.
    • 15.2.8. Natera, Inc.
    • 15.2.9. Freenome Holdings, Inc.
    • 15.2.10. QIAGEN N.V.
    • 15.2.11. Lucence Diagnostics
    • 15.2.12. Inivata Ltd. (NeoGenomics subsidiary)
    • 15.2.13. Angle plc
    • 15.2.14. Sysmex Corporation
    • 15.2.15. Biocept, Inc.
    • 15.2.16. Oncocyte Corporation
    • 15.2.17. Personal Genome Diagnostics (PGDx)
    • 15.2.18. Chronix Biomedical
    • 15.2.19. Epic Sciences, Inc.
    • 15.2.20. Cynvenio Biosystems, Inc.
    • 15.2.21. Others

16. 360 Degree Analyst View

17. Appendix

  • 17.1. Research Methodology
  • 17.2. References
  • 17.3. Abbreviations
  • 17.4. Disclaimer
  • 17.5. Contact Us